Clinical Trial Update: Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Fluoroethyltyrosine for the evaluation of intracranial neoplasms, including low-grade glioma and recurrent gliomas; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Intracranial Neoplasms
• Low-grade Glioma
• Who Grade Ii Glioma
• Who Grade Iii Glioma

Drugs mentioned

• Fluoroethyltyrosine (fluoroethyltyrosine)

Snippet

Sponsor: Thomas Hope | Conditions: Intracranial Neoplasm, Low Grade Glioma | Phase 2 | Status: COMPLETED